Overview
Smart money at a glance
Filings to Oct 13, 2026Net selling: insiders sold $16K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$16K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 12- Open
- $1.75
- 52-wk high
- $2.58
- High
- $1.82
- 52-wk low
- $1.18
- Low
- $1.73
- Prev close
- $1.77
- Mkt cap
- $481.8M
- Volume
- 1.48M
- Beta
- 2.14
- P/S
- 4.1x
- P/B
- 6.9x
- Profit margin
- -238.6%
- Op margin
- -96.0%
- ROE
- -133.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about AUTL filings
Are insiders buying or selling Autolus Therapeutics Ltd (AUTL) stock?
Net selling: insiders sold $16K and bought $0 of AUTL stock on the open market in the 90 days to Oct 13, 2026, according to SEC Form 4 filings. The largest was Piccina, Cintia (U.S. CCO & Country Gen Manager), who sold $16K. The latest filing was on Sep 3, 2026.
Which members of Congress have traded AUTL recently?
None. No member of Congress disclosed a AUTL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this AUTL smart-money data?
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
Sells (1)
- PC
Piccina Cintia
$16K
sold
How top traders are positioned
No tracked top-trader positions in AUTL right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 28.6% above what analysts expected.
Last report
Aug 11, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.21 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 11, 2026 | -$0.15 / -$0.21Alpha Vantage | +28.57% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 14, 2026 | -$0.27 / -$0.26Alpha Vantage | -3.85% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 27, 2026 | -$0.34 / -$0.25Alpha Vantage | -35.67% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 12, 2025 | -$0.30 / -$0.23Alpha Vantage | -30.43% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 12, 2025 | -$0.18 / -$0.23Alpha Vantage | +21.74% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$0.26 / -$0.26Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 20, 2025 | -$0.09 / -$0.24Alpha Vantage | +62.50% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.31 / -$0.22Alpha Vantage | -40.91% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 11, 2026, in 29 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -238.6%
- Market cap
- $482M
Valuation
- P/S4.10
- P/B6.94
Quality
- Operating margin-96.0%
- ROE-133.0%
- ROA-25.4%
Growth
- Beta2.14
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace